TreeWAS – Variant ID: rs7769051

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
J22 Unspecified acute lower respiratory infection	0.706	0.294	0.000
J20-J22 Other acute lower respiratory infections	0.683	0.317	0.000
Chapter X Diseases of the respiratory system	0.673	0.327	0.000
J80-J84 Other respiratory diseases principally affecting the interstitium	0.652	0.348	0.000
J95-J99 Other diseases of the respiratory system	0.642	0.358	0.000
J90-J94 Other diseases of pleura	0.642	0.358	0.000
J40-J47 Chronic lower respiratory diseases	0.624	0.376	0.000
J93 Pneumothorax	0.624	0.376	0.000
J43 Emphysema	0.622	0.378	0.000
J43.9 Emphysema, unspecified	0.619	0.381	0.000
J81 Pulmonary oedema	0.594	0.406	0.000
J93.9 Pneumothorax, unspecified	0.587	0.413	0.000
J93.1 Other spontaneous pneumothorax	0.585	0.415	0.000
J80 Adult respiratory distress syndrome	0.577	0.423	0.000
J98 Other respiratory disorders	0.572	0.428	0.000
J44 Other chronic obstructive pulmonary disease	0.566	0.434	0.000
J92 Pleural plaque	0.562	0.438	0.000
J98.4 Other disorders of lung	0.558	0.442	0.000
J99 Respiratory disorders in diseases classified elsewhere	0.556	0.444	0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.540	0.460	0.000
J95 Postprocedural respiratory disorders, not elsewhere classified	0.521	0.479	0.000
J82 Pulmonary eosinophilia, not elsewhere classified	0.510	0.490	0.000
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.506	0.494	0.000
J43.2 Centrilobular emphysema	0.505	0.495	0.000
J84 Other interstitial pulmonary diseases	0.495	0.505	0.000
J94 Other pleural conditions	0.493	0.507	0.000
J98.6 Disorders of diaphragm	0.487	0.513	0.000
J21 Acute bronchiolitis	0.486	0.514	0.000
J60-J70 Lung diseases due to external agents	0.485	0.515	0.000
J92.0 Pleural plaque with presence of asbestos	0.485	0.515	0.000
J44.8 Other specified chronic obstructive pulmonary disease	0.481	0.519	0.000
J91 Pleural effusion in conditions classified elsewhere	0.461	0.539	0.000
J96 Respiratory failure, not elsewhere classified	0.460	0.540	0.000
J99.1 Respiratory disorders in other diffuse connective tissue disorders	0.460	0.540	0.000
J99.8 Respiratory disorders in other diseases classified elsewhere	0.448	0.552	0.000
J41 Simple and mucopurulent chronic bronchitis	0.448	0.552	0.000
J43.8 Other emphysema	0.446	0.554	0.000
J43.1 Panlobular emphysema	0.446	0.554	0.000
J43.0 MacLeod's syndrome	0.446	0.554	0.000
J92.9 Pleural plaque without asbestos	0.445	0.555	0.000
J84.9 Interstitial pulmonary disease, unspecified	0.445	0.555	0.000
J42 Unspecified chronic bronchitis	0.431	0.569	0.000
J46 Status asthmaticus	0.424	0.576	0.000
J94.2 Haemothorax	0.423	0.577	0.000
J95.8 Other postprocedural respiratory disorders	0.411	0.589	0.000
J98.3 Compensatory emphysema	0.410	0.590	0.000
J98.2 Interstitial emphysema	0.410	0.590	0.000
J99.0 Rheumatoid lung disease	0.408	0.591	0.000
J93.0 Spontaneous tension pneumothorax	0.408	0.592	0.000
J95.0 Tracheostomy malfunction	0.404	0.596	0.000
J93.8 Other pneumothorax	0.393	0.607	0.000
J98.8 Other specified respiratory disorders	0.392	0.608	0.000
J20 Acute bronchitis	0.391	0.608	0.000
J98.9 Respiratory disorder, unspecified	0.379	0.621	0.000
J86 Pyothorax	0.377	0.623	0.000
J85 Abscess of lung and mediastinum	0.374	0.626	0.000
J95.9 Postprocedural respiratory disorder, unspecified	0.373	0.627	0.000
J95.5 Postprocedural subglottic stenosis	0.373	0.627	0.000
J95.4 Mendelson's syndrome	0.373	0.627	0.000
J95.3 Chronic pulmonary insufficiency following surgery	0.373	0.627	0.000
J95.2 Acute pulmonary insufficiency following nonthoracic surgery	0.373	0.627	0.000
J95.1 Acute pulmonary insufficiency following thoracic surgery	0.373	0.627	0.000
J64 Unspecified pneumoconiosis	0.366	0.633	0.000
J98.5 Diseases of mediastinum, not elsewhere classified	0.366	0.634	0.000
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.362	0.638	0.000
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.361	0.639	0.000
J98.0 Diseases of bronchus, not elsewhere classified	0.356	0.644	0.000
J84.0 Alveolar and parietoalveolar conditions	0.355	0.645	0.000
J94.9 Pleural condition, unspecified	0.353	0.647	0.000
J94.0 Chylous effusion	0.353	0.647	0.000
J21.8 Acute bronchiolitis due to other specified organisms	0.349	0.651	0.000
J21.1 Acute bronchiolitis due to human metapneumovirus	0.349	0.651	0.000
J21.0 Acute bronchiolitis due to respiratory syncytial virus	0.349	0.651	0.000
J70 Respiratory conditions due to other external agents	0.348	0.652	0.000
J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours	0.348	0.652	0.000
J66 Airway disease due to specific organic dust	0.348	0.652	0.000
J63 Pneumoconiosis due to other inorganic dusts	0.348	0.652	0.000
J62 Pneumoconiosis due to dust containing silica	0.348	0.652	0.000
J65 Pneumoconiosis associated with tuberculosis	0.348	0.652	0.000
J60 Coalworker's pneumoconiosis	0.348	0.652	0.000
J21.9 Acute bronchiolitis, unspecified	0.345	0.654	0.000
J69 Pneumonitis due to solids and liquids	0.341	0.659	0.000
J96.9 Respiratory failure, unspecified	0.330	0.670	0.000
J96.1 Chronic respiratory failure	0.330	0.670	0.000
J96.0 Acute respiratory failure	0.330	0.670	0.000
J94.1 Fibrothorax	0.328	0.672	0.000
J00-J06 Acute upper respiratory infections	0.322	0.678	0.000
J67 Hypersensitivity pneumonitis due to organic dust	0.321	0.679	0.000
J41.8 Mixed simple and mucopurulent chronic bronchitis	0.321	0.679	0.000
J41.1 Mucopurulent chronic bronchitis	0.321	0.679	0.000
J41.0 Simple chronic bronchitis	0.321	0.679	0.000
J94.8 Other specified pleural conditions	0.313	0.687	0.000
J84.8 Other specified interstitial pulmonary diseases	0.307	0.693	0.000
J86.0 Pyothorax with fistula	0.307	0.693	0.000
J40 Bronchitis, not specified as acute or chronic	0.290	0.710	0.000
J20.7 Acute bronchitis due to echovirus	0.281	0.719	0.000
J20.6 Acute bronchitis due to rhinovirus	0.281	0.719	0.000
J20.5 Acute bronchitis due to respiratory syncytial virus	0.281	0.719	0.000
J20.4 Acute bronchitis due to parainfluenza virus	0.281	0.719	0.000
J20.3 Acute bronchitis due to coxsackie virus	0.281	0.719	0.000
J20.2 Acute bronchitis due to streptococcus	0.281	0.719	0.000
J20.1 Acute bronchitis due to Haemophilus influenzae	0.281	0.719	0.000
J20.0 Acute bronchitis due to Mycoplasma pneumoniae	0.281	0.719	0.000
J85.1 Abscess of lung with pneumonia	0.279	0.721	0.000
J20.8 Acute bronchitis due to other specified organisms	0.276	0.724	0.000
J01 Acute sinusitis	0.271	0.729	0.000
J85.3 Abscess of mediastinum	0.268	0.732	0.000
J85.2 Abscess of lung without pneumonia	0.268	0.732	0.000
J85.0 Gangrene and necrosis of lung	0.268	0.732	0.000
J84.1 Other interstitial pulmonary diseases with fibrosis	0.262	0.738	0.000
J05 Acute obstructive laryngitis [croup] and epiglottitis	0.261	0.738	0.000
J62.8 Pneumoconiosis due to other dust containing silica	0.250	0.750	0.000
J62.0 Pneumoconiosis due to talc dust	0.250	0.750	0.000
J63.8 Pneumoconiosis due to other specified inorganic dusts	0.250	0.750	0.000
J63.5 Stannosis	0.250	0.750	0.000
J63.4 Siderosis	0.250	0.750	0.000
J63.3 Graphite fibrosis (of lung)	0.250	0.750	0.000
J63.2 Berylliosis	0.250	0.750	0.000
J63.1 Bauxite fibrosis (of lung)	0.250	0.750	0.000
J63.0 Aluminosis (of lung)	0.250	0.750	0.000
J66.8 Airway disease due to other specific organic dusts	0.250	0.750	0.000
J66.2 Cannabinosis	0.250	0.750	0.000
J66.1 Flax-dresser's disease	0.250	0.750	0.000
J66.0 Byssinosis	0.250	0.750	0.000
J68.9 Unspecified respiratory condition due to chemicals, gases, fumes and vapours	0.250	0.750	0.000
J68.8 Other respiratory conditions due to chemicals, gases, fumes and vapours	0.250	0.750	0.000
J68.4 Chronic respiratory conditions due to chemicals, gases, fumes and vapours	0.250	0.750	0.000
J68.3 Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours	0.250	0.750	0.000
J68.2 Upper respiratory inflammation due to chemicals, gases, fumes and vapours, not elsewhere classified	0.250	0.750	0.000
J68.1 Acute pulmonary oedema due to chemicals, gases, fumes and vapours	0.250	0.750	0.000
J68.0 Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours	0.250	0.750	0.000
J70.9 Respiratory conditions due to unspecified external agent	0.250	0.750	0.000
J70.8 Respiratory conditions due to other specified external agents	0.250	0.750	0.000
J70.4 Drug-induced interstitial lung disorder, unspecified	0.250	0.750	0.000
J70.3 Chronic drug-induced interstitial lung disorders	0.250	0.750	0.000
J70.2 Acute drug-induced interstitial lung disorders	0.250	0.750	0.000
J70.1 Chronic and other pulmonary manifestations due to radiation	0.250	0.750	0.000
J70.0 Acute pulmonary manifestations due to radiation	0.250	0.750	0.000
J69.8 Pneumonitis due to other solids and liquids	0.245	0.755	0.000
J69.1 Pneumonitis due to oils and essences	0.245	0.755	0.000
J86.9 Pyothorax without fistula	0.237	0.762	0.000
J69.0 Pneumonitis due to food and vomit	0.237	0.763	0.000
J01.2 Acute ethmoidal sinusitis	0.237	0.763	0.000
J96.09 Acute respiratory failure; Type unspecified	0.237	0.763	0.000
J96.01 Acute respiratory failure; Type II [hypercapnic]	0.237	0.763	0.000
J96.00 Acute respiratory failure; Type I [hypoxic]	0.237	0.763	0.000
J96.19 Chronic respiratory failure; Type unspecified	0.237	0.763	0.000
J96.11 Chronic respiratory failure; Type II [hypercapnic]	0.237	0.763	0.000
J96.10 Chronic respiratory failure; Type I [hypoxic]	0.237	0.763	0.000
J96.99 Respiratory failure, unspecified; Type unspecified	0.237	0.763	0.000
J96.91 Respiratory failure unspecified; Type II [hypercapnic]	0.237	0.763	0.000
J96.90 Respiratory failure, unspecified; Type I [hypoxic]	0.237	0.763	0.000
J03 Acute tonsillitis	0.237	0.763	0.000
J67.8 Hypersensitivity pneumonitis due to other organic dusts	0.230	0.769	0.000
J67.7 Air-conditioner and humidifier lung	0.230	0.769	0.000
J67.6 Maple-bark-stripper's lung	0.230	0.769	0.000
J67.5 Mushroom-worker's lung	0.230	0.769	0.000
J67.4 Maltworker's lung	0.230	0.769	0.000
J67.3 Suberosis	0.230	0.769	0.000
J67.2 Bird fancier's lung	0.230	0.769	0.000
J67.1 Bagassosis	0.230	0.769	0.000
J67.0 Farmer's lung	0.230	0.769	0.000
J01.0 Acute maxillary sinusitis	0.219	0.781	0.000
J05.1 Acute epiglottitis	0.218	0.782	0.000
J67.9 Hypersensitivity pneumonitis due to unspecified organic dust	0.204	0.796	0.000
J44.9 Chronic obstructive pulmonary disease, unspecified	0.198	0.802	0.000
J01.8 Other acute sinusitis	0.195	0.805	0.000
J01.4 Acute pansinusitis	0.195	0.805	0.000
J01.3 Acute sphenoidal sinusitis	0.195	0.805	0.000
J01.1 Acute frontal sinusitis	0.195	0.805	0.000
J20.9 Acute bronchitis, unspecified	0.192	0.808	0.001
J05.0 Acute obstructive laryngitis [croup]	0.188	0.812	0.000
J03.9 Acute tonsillitis, unspecified	0.176	0.824	0.000
J02 Acute pharyngitis	0.172	0.828	0.000
J06 Acute upper respiratory infections of multiple and unspecified sites	0.172	0.828	0.000
J04 Acute laryngitis and tracheitis	0.170	0.829	0.001
J03.8 Acute tonsillitis due to other specified organisms	0.170	0.830	0.000
J03.0 Streptococcal tonsillitis	0.170	0.830	0.000
J00 Acute nasopharyngitis [common cold]	0.160	0.840	0.000
J01.9 Acute sinusitis, unspecified	0.154	0.846	0.000
W20-W49 Exposure to inanimate mechanical forces	0.144	0.856	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.141	0.859	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.140	0.860	0.000
J45 Asthma	0.139	0.861	0.000
W22 Striking against or struck by other objects	0.137	0.863	0.000
Chapter XX External causes of morbidity and mortality	0.134	0.866	0.000
W49 Exposure to other and unspecified inanimate mechanical forces	0.129	0.871	0.000
W22.9 Unspecified place	0.127	0.873	0.000
W44 Foreign body entering into or through eye or natural orifice	0.126	0.874	0.000
J04.1 Acute tracheitis	0.125	0.875	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.125	0.875	0.000
W21 Striking against or struck by sports equipment	0.124	0.875	0.000
J02.8 Acute pharyngitis due to other specified organisms	0.123	0.876	0.000
J02.0 Streptococcal pharyngitis	0.123	0.876	0.000
J06.8 Other acute upper respiratory infections of multiple sites	0.123	0.876	0.000
J06.0 Acute laryngopharyngitis	0.123	0.876	0.000
J98.1 Pulmonary collapse	0.123	0.877	0.000
J04.2 Acute laryngotracheitis	0.122	0.877	0.001
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.123	0.877	0.000
Y42.5 Other oestrogens and progestogens	0.123	0.877	0.000
Y40 Systemic antibiotics	0.120	0.880	0.000
Y42.1 Thyroid hormones and substitutes	0.120	0.880	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.119	0.881	0.000
Y59 Other and unspecified vaccines and biological substances	0.118	0.882	0.000
W45 Foreign body or object entering through skin	0.117	0.883	0.000
W25 Contact with sharp glass	0.116	0.884	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.115	0.885	0.000
W44.0 Home	0.114	0.886	0.000
W49.9 Unspecified place	0.114	0.886	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.113	0.887	0.000
X60-X84 Intentional self-harm	0.112	0.888	0.000
W21.9 Unspecified place	0.111	0.889	0.000
Y57 Other and unspecified drugs and medicaments	0.111	0.889	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.111	0.889	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.110	0.890	0.000
Y42.7 Androgens and anabolic congeners	0.110	0.890	0.000
W22.2 School, other institution and public administrative area	0.109	0.891	0.000
X40-X49 Accidental poisoning by and exposure to noxious substances	0.109	0.891	0.000
J09-J18 Influenza and pneumonia	0.109	0.891	0.000
X00-X09 Exposure to smoke, fire and flames	0.109	0.891	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.107	0.893	0.000
W22.5 Trade and service area	0.107	0.893	0.000
W50-W64 Exposure to animate mechanical forces	0.105	0.895	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.105	0.895	0.000
W27 Contact with nonpowered hand tool	0.105	0.895	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.104	0.896	0.000
V98-V99 Other and unspecified transport accidents	0.104	0.896	0.000
W49.0 Home	0.104	0.896	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.104	0.896	0.000
W46 Contact with hypodermic needle	0.103	0.897	0.000
W43 Exposure to vibration	0.103	0.897	0.000
W42 Exposure to noise	0.103	0.897	0.000
W41 Exposure to high-pressure jet	0.103	0.897	0.000
W40 Explosion of other materials	0.103	0.897	0.000
W39 Discharge of firework	0.103	0.897	0.000
W38 Explosion and rupture of other specified pressurised devices	0.103	0.897	0.000
W37 Explosion and rupture of pressurised tyre, pipe or hose	0.103	0.897	0.000
W36 Explosion and rupture of gas cylinder	0.103	0.897	0.000
W35 Explosion and rupture of boiler	0.103	0.897	0.000
W34 Discharge from other and unspecified firearms	0.103	0.897	0.000
W33 Rifle, shotgun and larger firearm discharge	0.103	0.897	0.000
W32 Handgun discharge	0.103	0.897	0.000
W31 Contact with other and unspecified machinery	0.103	0.897	0.000
W30 Contact with agricultural machinery	0.103	0.897	0.000
W28 Contact with powered lawn mower	0.103	0.897	0.000
W26 Contact with knife, sword or dagger	0.103	0.897	0.000
W24 Contact with lifting and transmission devices, not elsewhere classified	0.103	0.897	0.000
Y00-Y09 Assault	0.102	0.898	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.102	0.898	0.000
Y59.3 Immunoglobulin	0.102	0.898	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.102	0.898	0.000
Y58 Bacterial vaccines	0.101	0.898	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.101	0.898	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.101	0.898	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.101	0.899	0.000
W22.3 Sports and athletics area	0.101	0.899	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.101	0.899	0.000
Y42.9 Other and unspecified hormone antagonists	0.100	0.899	0.000
Y42.4 Oral contraceptives	0.100	0.899	0.000
Y42.2 Antithyroid drugs	0.100	0.899	0.000
X10-X19 Contact with heat and hot substances	0.100	0.899	0.000
J45.8 Mixed asthma	0.100	0.900	0.000
J45.1 Nonallergic asthma	0.100	0.900	0.000
V95-V97 Air and space transport accidents	0.099	0.901	0.000
Y57.8 Other drugs and medicaments	0.099	0.901	0.000
Y45.1 Salicylates	0.098	0.902	0.000
W22.8 Other specified place	0.098	0.902	0.000
W22.6 Industrial and construction area	0.098	0.902	0.000
W22.4 Street and highway	0.098	0.902	0.000
W22.0 Home	0.098	0.902	0.000
W22.7 Farm	0.098	0.902	0.000
W22.1 Residential institution	0.098	0.902	0.000
W23 Caught, crushed, jammed or pinched in or between objects	0.098	0.902	0.000
W25.9 Unspecified place	0.097	0.903	0.000
W45.5 Trade and service area	0.096	0.904	0.000
Y35-Y36 Legal intervention and operations of war	0.096	0.904	0.000
Y10-Y34 Event of undetermined intent	0.096	0.904	0.000
X85-X99 Assault	0.096	0.904	0.000
X30-X39 Exposure to forces of nature	0.096	0.904	0.000
W75-W84 Other accidental threats to breathing	0.096	0.904	0.000
W65-W74 Accidental drowning and submersion	0.096	0.904	0.000
V90-V94 Water transport accidents	0.096	0.904	0.000
V70-V79 Bus occupant injured in transport accident	0.096	0.904	0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.096	0.904	0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.096	0.904	0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.096	0.904	0.000
V20-V29 Motorcycle rider injured in transport accident	0.096	0.904	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.096	0.904	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.095	0.905	0.000
V01-V09 Pedestrian injured in transport accident	0.095	0.905	0.000
Y45.8 Other analgesics and antipyretics	0.094	0.906	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.094	0.906	0.000
Y40.3 Macrolides	0.093	0.907	0.000
V40-V49 Car occupant injured in transport accident	0.093	0.907	0.000
W49.8 Other specified place	0.093	0.907	0.000
W49.7 Farm	0.093	0.907	0.000
W49.6 Industrial and construction area	0.093	0.907	0.000
W49.5 Trade and service area	0.093	0.907	0.000
W49.4 Street and highway	0.093	0.907	0.000
W49.3 Sports and athletics area	0.093	0.907	0.000
W49.2 School, other institution and public administrative area	0.093	0.907	0.000
W49.1 Residential institution	0.093	0.907	0.000
Y40.8 Other systemic antibiotics	0.092	0.908	0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.092	0.908	0.000
X50-X57 Overexertion, travel and privation	0.092	0.908	0.000
W20 Struck by thrown, projected or falling object	0.091	0.908	0.000
Y44 Agents primarily affecting blood constituents	0.091	0.908	0.000
X00 Exposure to uncontrolled fire in building or structure	0.091	0.909	0.000
W44.9 Unspecified place	0.091	0.909	0.000
W44.5 Trade and service area	0.091	0.909	0.000
W44.8 Other specified place	0.091	0.909	0.000
W44.7 Farm	0.091	0.909	0.000
W44.6 Industrial and construction area	0.091	0.909	0.000
W44.4 Street and highway	0.091	0.909	0.000
W44.3 Sports and athletics area	0.091	0.909	0.000
W44.2 School, other institution and public administrative area	0.091	0.909	0.000
W44.1 Residential institution	0.091	0.909	0.000
Y43 Primarily systemic agents	0.091	0.909	0.000
Y48 Anaesthetics and therapeutic gases	0.090	0.909	0.000
Y46.7 Anti-Parkinsonism drugs	0.090	0.910	0.000
X43 Accidental poisoning by and exposure to other drugs acting on the autonomic nervous system	0.089	0.910	0.000
W21.3 Sports and athletics area	0.089	0.910	0.000
W21.8 Other specified place	0.089	0.910	0.000
W21.7 Farm	0.089	0.910	0.000
W21.6 Industrial and construction area	0.089	0.910	0.000
W21.5 Trade and service area	0.089	0.910	0.000
W21.4 Street and highway	0.089	0.910	0.000
W21.2 School, other institution and public administrative area	0.089	0.910	0.000
W21.1 Residential institution	0.089	0.910	0.000
W21.0 Home	0.089	0.910	0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.089	0.911	0.000
W29 Contact with other powered hand tools and household machinery	0.089	0.911	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.088	0.912	0.000
Y45.5 4-Aminophenol derivatives	0.088	0.912	0.000
Y45.4 Antirheumatics	0.088	0.912	0.000
Y53.4 Other laxatives	0.088	0.912	0.000
X20-X29 Contact with venomous animals and plants	0.088	0.912	0.000
W45.8 Other specified place	0.088	0.912	0.000
X68 Intentional self-poisoning by and exposure to pesticides	0.088	0.912	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.088	0.912	0.000
X65 Intentional self-poisoning by and exposure to alcohol	0.087	0.913	0.000
X49 Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances	0.087	0.913	0.000
V80-V89 Other land transport accidents	0.087	0.913	0.000
Y52 Agents primarily affecting the cardiovascular system	0.087	0.913	0.000
Y71 Cardiovascular devices associated with adverse incidents	0.086	0.914	0.000
Y40.7 Antifungal antibiotics, systemically used	0.086	0.914	0.000
Y40.6 Rifamycins	0.086	0.914	0.000
Y40.5 Aminoglycosides	0.086	0.914	0.000
Y40.4 Tetracyclines	0.086	0.914	0.000
Y40.2 Chloramphenicol group	0.086	0.914	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.085	0.915	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.085	0.915	0.000
Y53.7 Emetics	0.085	0.915	0.000
Y53.6 Antidiarrhoeal drugs	0.085	0.915	0.000
Y53.5 Digestants	0.085	0.915	0.000
Y53.3 Saline and osmotic laxatives	0.085	0.915	0.000
Y53.2 Stimulant laxatives	0.085	0.915	0.000
Y53.0 Histamine H2-receptor antagonists	0.085	0.915	0.000
Y57.5 X-ray contrast media	0.085	0.915	0.000
Y59.9 Vaccine or biological substance, unspecified	0.085	0.915	0.000
Y59.8 Other specified vaccines and biological substances	0.085	0.915	0.000
Y59.2 Protozoal vaccines	0.085	0.915	0.000
Y59.1 Rickettsial vaccines	0.085	0.915	0.000
Y59.0 Viral vaccines	0.085	0.915	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.085	0.915	0.000
W45.9 Unspecified place	0.084	0.916	0.000
W45.0 Home	0.084	0.916	0.000
W45.7 Farm	0.084	0.916	0.000
W45.6 Industrial and construction area	0.084	0.916	0.000
W45.4 Street and highway	0.084	0.916	0.000
W45.3 Sports and athletics area	0.084	0.916	0.000
W45.2 School, other institution and public administrative area	0.084	0.916	0.000
W45.1 Residential institution	0.084	0.916	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.084	0.916	0.000
W25.6 Industrial and construction area	0.084	0.916	0.000
W25.5 Trade and service area	0.084	0.916	0.000
W25.1 Residential institution	0.084	0.916	0.000
W25.0 Home	0.084	0.916	0.000
W25.8 Other specified place	0.084	0.916	0.000
W25.7 Farm	0.084	0.916	0.000
W25.4 Street and highway	0.084	0.916	0.000
W25.3 Sports and athletics area	0.084	0.916	0.000
W25.2 School, other institution and public administrative area	0.084	0.916	0.000
W94 Exposure to high and low air pressure and changes in air pressure	0.083	0.917	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.083	0.917	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.083	0.917	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.083	0.917	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.083	0.917	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.083	0.917	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.083	0.917	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.083	0.917	0.000
Y51.0 Anticholinesterase agents	0.083	0.917	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.083	0.917	0.000
V99 Unspecified transport accident	0.083	0.917	0.000
W55 Bitten or struck by other mammals	0.082	0.918	0.000
J10 Influenza due to identified influenza virus	0.082	0.918	0.000
Y54.8 Agents affecting uric acid metabolism	0.082	0.918	0.000
Y79 Orthopaedic devices associated with adverse incidents	0.081	0.918	0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.081	0.919	0.000
V10-V19 Pedal cyclist injured in transport accident	0.081	0.919	0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.081	0.919	0.000
W60 Contact with plant thorns and spines and sharp leaves	0.080	0.920	0.000
Y04 Assault by bodily force	0.080	0.920	0.000
X84 Intentional self-harm by unspecified means	0.080	0.920	0.000
X83 Intentional self-harm by other specified means	0.080	0.920	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.080	0.920	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.080	0.920	0.000
X80 Intentional self-harm by jumping from a high place	0.080	0.920	0.000
X79 Intentional self-harm by blunt object	0.080	0.920	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.080	0.920	0.000
X76 Intentional self-harm by smoke, fire and flames	0.080	0.920	0.000
X75 Intentional self-harm by explosive material	0.080	0.920	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.080	0.920	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.080	0.920	0.000
X72 Intentional self-harm by handgun discharge	0.080	0.920	0.000
X71 Intentional self-harm by drowning and submersion	0.080	0.920	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.080	0.920	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.080	0.920	0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.080	0.920	0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.080	0.920	0.000
J17 Pneumonia in diseases classified elsewhere	0.080	0.920	0.000
Y40.9 Systemic antibiotic, unspecified	0.080	0.920	0.000
Y57.7 Vitamins, not elsewhere classified	0.080	0.920	0.000
Y57.6 Other diagnostic agents	0.080	0.920	0.000
Y57.4 Pharmaceutical excipients	0.080	0.920	0.000
Y57.3 Alcohol deterrents	0.080	0.920	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.080	0.920	0.000
Y57.1 Lipotropic drugs	0.080	0.920	0.000
Y57.0 Appetite depressants [anorectics]	0.080	0.920	0.000
Y87 Sequelae of intentional self-harm, assault and events of undetermined intent	0.080	0.920	0.000
Y46.8 Antispasticity drugs	0.079	0.921	0.000
Y46.6 Other and unspecified antiepileptics	0.079	0.921	0.000
Y46.5 Valproic acid	0.079	0.921	0.000
Y46.3 Deoxybarbiturates	0.079	0.921	0.000
Y46.1 Oxazolidinediones	0.079	0.921	0.000
Y46.0 Succinimides	0.079	0.921	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.079	0.921	0.000
W57 Bitten or stung by non-venomous insect and other non-venomous arthropods	0.079	0.921	0.000
X10 Contact with hot drinks, food, fats and cooking oils	0.078	0.921	0.000
X48 Accidental poisoning by and exposure to pesticides	0.078	0.922	0.000
X47 Accidental poisoning by and exposure to other gases and vapours	0.078	0.922	0.000
X46 Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.078	0.922	0.000
X44 Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.078	0.922	0.000
X42 Accidental poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.078	0.922	0.000
X40 Accidental poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.078	0.922	0.000
J16 Pneumonia due to other infectious organisms, not elsewhere classified	0.078	0.922	0.000
J12 Viral pneumonia, not elsewhere classified	0.078	0.922	0.000
J09 Influenza due to certain identified influenza virus	0.078	0.922	0.000
X00.0 Home	0.078	0.922	0.000
X09 Exposure to unspecified smoke, fire and flames	0.078	0.922	0.000
X08 Exposure to other specified smoke, fire and flames	0.078	0.922	0.000
X06 Exposure to ignition or melting of other clothing and apparel	0.078	0.922	0.000
X05 Exposure to ignition or melting of nightwear	0.078	0.922	0.000
X04 Exposure to ignition of highly flammable material	0.078	0.922	0.000
X03 Exposure to controlled fire, not in building or structure	0.078	0.922	0.000
X02 Exposure to controlled fire in building or structure	0.078	0.922	0.000
X01 Exposure to uncontrolled fire, not in building or structure	0.078	0.922	0.000
X78 Intentional self-harm by sharp object	0.078	0.922	0.000
Y46.2 Hydantoin derivatives	0.077	0.922	0.000
Y46.4 Iminostilbenes	0.077	0.923	0.000
X58-X59 Accidental exposure to other and unspecified factors	0.077	0.923	0.000
Y82 Other and unspecified medical devices associated with adverse incidents	0.077	0.923	0.000
Y81 General- and plastic-surgery devices associated with adverse incidents	0.077	0.923	0.000
Y80 Physical medicine devices associated with adverse incidents	0.077	0.923	0.000
Y78 Radiological devices associated with adverse incidents	0.077	0.923	0.000
Y76 Obstetric and gynaecological devices associated with adverse incidents	0.077	0.923	0.000
Y75 Neurological devices associated with adverse incidents	0.077	0.923	0.000
Y74 General hospital and personal-use devices associated with adverse incidents	0.077	0.923	0.000
Y73 Gastro-enterology and urology devices associated with adverse incidents	0.077	0.923	0.000
Y72 Otorhinolaryngological devices associated with adverse incidents	0.077	0.923	0.000
Y70 Anaesthesiology devices associated with adverse incidents	0.077	0.923	0.000
Y43.1 Antineoplastic antimetabolites	0.077	0.923	0.000
Y47.1 Benzodiazepines	0.077	0.923	0.000
W27.6 Industrial and construction area	0.077	0.923	0.000
Y77 Ophthalmic devices associated with adverse incidents	0.076	0.923	0.000
X43.0 Home	0.076	0.924	0.000
W64 Exposure to other and unspecified animate mechanical forces	0.076	0.924	0.000
W59 Bitten or crushed by other reptiles	0.076	0.924	0.000
W58 Bitten or struck by crocodile or alligator	0.076	0.924	0.000
W56 Contact with marine animal	0.076	0.924	0.000
W54 Bitten or struck by dog	0.076	0.924	0.000
W53 Bitten by rat	0.076	0.924	0.000
W52 Crushed, pushed and stepped on by crowd or human stampede	0.076	0.924	0.000
V48 Car occupant injured in noncollision transport accident	0.075	0.924	0.000
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.075	0.925	0.000
W27.9 Unspecified place	0.075	0.925	0.000
W27.0 Home	0.075	0.925	0.000
W27.8 Other specified place	0.075	0.925	0.000
W27.7 Farm	0.075	0.925	0.000
W27.5 Trade and service area	0.075	0.925	0.000
W27.4 Street and highway	0.075	0.925	0.000
W27.3 Sports and athletics area	0.075	0.925	0.000
W27.2 School, other institution and public administrative area	0.075	0.925	0.000
W27.1 Residential institution	0.075	0.925	0.000
W99 Exposure to other and unspecified man-made environmental factors	0.075	0.925	0.000
W93 Exposure to excessive cold of man-made origin	0.075	0.925	0.000
W92 Exposure to excessive heat of man-made origin	0.075	0.925	0.000
W91 Exposure to unspecified type of radiation	0.075	0.925	0.000
W90 Exposure to other nonionising radiation	0.075	0.925	0.000
W89 Exposure to man-made visible and ultraviolet light	0.075	0.925	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations